Literature DB >> 2436008

Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril.

W H van Gilst, P A de Graeff, E Scholtens, C D de Langen, H Wesseling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2436008     DOI： 10.1097/00005344-198702000-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  8 in total

Review 1.  Mechanisms of nitrate tolerance: a review.

Authors:  R J Katz
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 2.  The renin-angiotensin system and cardiac remodelling after acute myocardial infarction.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.

Authors:  K Phillips; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

Review 6.  Pharmacokinetics of angiotensin converting enzyme inhibitors.

Authors:  M Burnier; B Waeber; J Nussberger; H R Brunner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 7.  Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.

Authors:  V J Dzau
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 8.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.